147 related articles for article (PubMed ID: 12501560)
1. [Evaluation of survival in mixed connective tissue disease (MCTD)].
Bodolay E; Gaál J; Végh J; Soltész P; Szodoray P; Lakos G; Nemes Z; Dezsö B; Szegedi G
Orv Hetil; 2002 Nov; 143(45):2543-8. PubMed ID: 12501560
[TBL] [Abstract][Full Text] [Related]
2. Clinical course, prognosis, and causes of death in mixed connective tissue disease.
Hajas A; Szodoray P; Nakken B; Gaal J; Zöld E; Laczik R; Demeter N; Nagy G; Szekanecz Z; Zeher M; Szegedi G; Bodolay E
J Rheumatol; 2013 Jul; 40(7):1134-42. PubMed ID: 23637328
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.
Vegh J; Szodoray P; Kappelmayer J; Csipo I; Udvardy M; Lakos G; Aleksza M; Soltesz P; Szilágyi A; Zeher M; Szegedi G; Bodolay E
Scand J Immunol; 2006 Jul; 64(1):69-76. PubMed ID: 16784493
[TBL] [Abstract][Full Text] [Related]
4. [A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension].
Sasaki N; Kurose A; Inoue H; Sawai T
Ryumachi; 2002 Dec; 42(6):885-94. PubMed ID: 12632608
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.
Burdt MA; Hoffman RW; Deutscher SL; Wang GS; Johnson JC; Sharp GC
Arthritis Rheum; 1999 May; 42(5):899-909. PubMed ID: 10323445
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
[TBL] [Abstract][Full Text] [Related]
7. Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels.
Hajas A; Szodoray P; Barath S; Sipka S; Rezes S; Zeher M; Sziklai I; Szegedi G; Bodolay E
J Rheumatol; 2009 Sep; 36(9):1930-6. PubMed ID: 19684145
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura associated with mixed connective tissue disease.
Kato A; Suzuki Y; Fujigaki Y; Yamamoto T; Yonemura K; Miyajima H; Hishida A
Rheumatol Int; 2002 Jul; 22(3):122-5. PubMed ID: 12111089
[TBL] [Abstract][Full Text] [Related]
9. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
Hasegawa EM; Caleiro MT; Fuller R; Carvalho JF
Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462
[TBL] [Abstract][Full Text] [Related]
10. Distinct phenotypes in mixed connective tissue disease: subgroups and survival.
Szodoray P; Hajas A; Kardos L; Dezso B; Soos G; Zold E; Vegh J; Csipo I; Nakken B; Zeher M; Szegedi G; Bodolay E
Lupus; 2012 Nov; 21(13):1412-22. PubMed ID: 22864236
[TBL] [Abstract][Full Text] [Related]
11. Fatal primary pulmonary hypertension in mixed connective tissue disease.
Eulderink F; Cats A
Z Rheumatol; 1981; 40(1):25-9. PubMed ID: 7223079
[TBL] [Abstract][Full Text] [Related]
12. Anti-endothelial cell antibodies in the sera of patients with mixed connective tissue disease--the clinical significance.
Watanabe H; Kaise S; Takeda I; Matsuzaki H; Kobayashi H; Nishimaki T; Kasukawa R
Fukushima J Med Sci; 1997 Jun; 43(1):13-28. PubMed ID: 9431781
[TBL] [Abstract][Full Text] [Related]
13. [Thrombotic thrombocytopenic purpura with mixed connective tissue disease. A case report].
Kajita N; Muro Y; Tomita A; Hirashima K; Matsushita T; Naoe T; Tomita Y
Arerugi; 2009 May; 58(5):567-72. PubMed ID: 19487839
[TBL] [Abstract][Full Text] [Related]
14. Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.
Dahl M; Chalmers A; Wade J; Calverley D; Munt B
J Rheumatol; 1992 Nov; 19(11):1807-9. PubMed ID: 1491407
[TBL] [Abstract][Full Text] [Related]
15. [Puerperal secondary pulmonary hypertension in a patient with mixed connective tissue disease].
Watanabe R; Tatsumi K; Uchiyama T; Kato K; Okada O; Nagao K; Kuriyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):883-7. PubMed ID: 7474571
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
17. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study.
Hosoda Y; Suzuki Y; Takano M; Tojo T; Homma M
J Rheumatol; 1987 Aug; 14(4):826-30. PubMed ID: 3668989
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of mixed connective tissue disease.
Lundberg IE
Rheum Dis Clin North Am; 2005 Aug; 31(3):535-47, vii-viii. PubMed ID: 16084324
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension in a child with mixed connective tissue disease.
Rosenberg AM; Petty RE; Cumming GR; Koehler BE
J Rheumatol; 1979; 6(6):700-4. PubMed ID: 529255
[TBL] [Abstract][Full Text] [Related]
20. Mixed connective tissue disease--clinical and immunological profile.
Nedumaran ; Rajendran CP; Porkodi R; Parthiban R
J Assoc Physicians India; 2001 Apr; 49():412-4. PubMed ID: 11762609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
